One popular post called the ad "misunderstood but on point," arguing that Big Pharma has been overcharging ... triggered regulatory scrutiny. The New York Times reported that senators Richard ...

One group had not been held accountable — until a recent New York Times investigation exposed how Big Pharma incentivized pharmacy benefit managers not to restrict painkiller prescriptions.